Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-13-001992)

Filing Details

Accession Number:: 0001387131-13-001992
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-17 20:05:41
Reporting Period:: 2013-01-28

Filing Date:: 2013-05-17
Accepted Time:: 2013-05-17 20:05:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420031	Emmaus Life Sciences Inc.	NONE	Blank Checks (6770)	412254389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1546810	Peter Ludlum	20725 S. Western Ave Suite 136 Torrance CA 90501	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-28	3,000	$3.60	3,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Options	Acquisiton	2013-02-28	500,000	$0.00	500,000	$3.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
500,000		2023-02-27	No	4	A	Direct

Footnotes

The option vests on a cliff basis for the first one-third (1/3) granted and monthly on a prorata basis for the remaining two-thirds (2/3) thereafter in equal amounts (or as close to an equal amount as possible) over the next 24 months beginning on February 28, 2014.